The Evolution of Hemophilia Care: Clinical and Laboratory Advances, Opportunities, and Challenges

Abstract excerpt

Hemophilia A (HA) and B (HB) are X-linked bleeding disorders caused by mutations in the F8 or F9 gene that result in the absence, or reduced activity, of the corresponding clotting factor. The severity of bleeding and related complications is proportional to the amount of residual circulating functional factor. The development of a safe and effective hemophilia treatment lasted several decades and has been mainly...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Hemophilia Treatment and Research